Delipidation of plasma has minimal effects on human butyrylcholinesterase

Seda Onder, Ozden Tacal, Oksana Lockridge

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Human butyrylcholinesterase (BChE) is purified in large quantities from Cohn fraction IV-4 to use for protection against the toxicity of chemical warfare agents. Small scale preliminary experiments use outdated plasma from the American Red Cross as the starting material for purifying BChE (P06276). Many of the volunteer donor plasma samples are turbid with fat, the donor having eaten fatty food before the blood draw. The turbid fat interferes with enzyme assays performed in the spectrophotometer and with column chromatography. Our goal was to find a method to remove fat from plasma without loss of BChE activity. Satisfactory delipidation was achieved by adding a solution of 10% dextran sulfate and calcium chloride to fatty plasma, followed by centrifugation, and filtration through a 0.8 μm filter. Treatment with Aerosil also delipidated fatty plasma, but was accompanied by loss of 50% of the plasma volume. BChE activity and the BChE isozyme pattern on nondenaturing gel electrophoresis were unaffected by delipidation. BChE in delipidated plasma was efficiently captured by immobilized monoclonal antibodies B2 18-5 and mAb2. The immunopurified BChE was released from antibody binding with acid and visualized as a highly enriched, denatured BChE preparation by SDS gel electrophoresis. In conclusion, delipidation with dextran sulfate/CaCl2 preserves BChE activity and the tetramer structure of BChE.

Original languageEnglish (US)
Article number117
JournalFrontiers in Pharmacology
Volume9
Issue numberFEB
DOIs
StatePublished - Feb 15 2018

Fingerprint

Butyrylcholinesterase
Dextran Sulfate
Fats
Electrophoresis
Gels
Chemical Warfare Agents
Tissue Donors
Immobilized Antibodies
Red Cross
Calcium Chloride
Plasma Volume
Enzyme Assays
Centrifugation
Silicon Dioxide
Isoenzymes
Chromatography
Volunteers
Monoclonal Antibodies

Keywords

  • Aerosil 380F
  • Butyrylcholinesterase
  • Delipidation
  • Dextran sulfate
  • Fatty plasma
  • Monoclonal antibodies

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Delipidation of plasma has minimal effects on human butyrylcholinesterase. / Onder, Seda; Tacal, Ozden; Lockridge, Oksana.

In: Frontiers in Pharmacology, Vol. 9, No. FEB, 117, 15.02.2018.

Research output: Contribution to journalArticle

@article{e5599a7ca21544118f1e998b6df55f14,
title = "Delipidation of plasma has minimal effects on human butyrylcholinesterase",
abstract = "Human butyrylcholinesterase (BChE) is purified in large quantities from Cohn fraction IV-4 to use for protection against the toxicity of chemical warfare agents. Small scale preliminary experiments use outdated plasma from the American Red Cross as the starting material for purifying BChE (P06276). Many of the volunteer donor plasma samples are turbid with fat, the donor having eaten fatty food before the blood draw. The turbid fat interferes with enzyme assays performed in the spectrophotometer and with column chromatography. Our goal was to find a method to remove fat from plasma without loss of BChE activity. Satisfactory delipidation was achieved by adding a solution of 10{\%} dextran sulfate and calcium chloride to fatty plasma, followed by centrifugation, and filtration through a 0.8 μm filter. Treatment with Aerosil also delipidated fatty plasma, but was accompanied by loss of 50{\%} of the plasma volume. BChE activity and the BChE isozyme pattern on nondenaturing gel electrophoresis were unaffected by delipidation. BChE in delipidated plasma was efficiently captured by immobilized monoclonal antibodies B2 18-5 and mAb2. The immunopurified BChE was released from antibody binding with acid and visualized as a highly enriched, denatured BChE preparation by SDS gel electrophoresis. In conclusion, delipidation with dextran sulfate/CaCl2 preserves BChE activity and the tetramer structure of BChE.",
keywords = "Aerosil 380F, Butyrylcholinesterase, Delipidation, Dextran sulfate, Fatty plasma, Monoclonal antibodies",
author = "Seda Onder and Ozden Tacal and Oksana Lockridge",
year = "2018",
month = "2",
day = "15",
doi = "10.3389/fphar.2018.00117",
language = "English (US)",
volume = "9",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media S. A.",
number = "FEB",

}

TY - JOUR

T1 - Delipidation of plasma has minimal effects on human butyrylcholinesterase

AU - Onder, Seda

AU - Tacal, Ozden

AU - Lockridge, Oksana

PY - 2018/2/15

Y1 - 2018/2/15

N2 - Human butyrylcholinesterase (BChE) is purified in large quantities from Cohn fraction IV-4 to use for protection against the toxicity of chemical warfare agents. Small scale preliminary experiments use outdated plasma from the American Red Cross as the starting material for purifying BChE (P06276). Many of the volunteer donor plasma samples are turbid with fat, the donor having eaten fatty food before the blood draw. The turbid fat interferes with enzyme assays performed in the spectrophotometer and with column chromatography. Our goal was to find a method to remove fat from plasma without loss of BChE activity. Satisfactory delipidation was achieved by adding a solution of 10% dextran sulfate and calcium chloride to fatty plasma, followed by centrifugation, and filtration through a 0.8 μm filter. Treatment with Aerosil also delipidated fatty plasma, but was accompanied by loss of 50% of the plasma volume. BChE activity and the BChE isozyme pattern on nondenaturing gel electrophoresis were unaffected by delipidation. BChE in delipidated plasma was efficiently captured by immobilized monoclonal antibodies B2 18-5 and mAb2. The immunopurified BChE was released from antibody binding with acid and visualized as a highly enriched, denatured BChE preparation by SDS gel electrophoresis. In conclusion, delipidation with dextran sulfate/CaCl2 preserves BChE activity and the tetramer structure of BChE.

AB - Human butyrylcholinesterase (BChE) is purified in large quantities from Cohn fraction IV-4 to use for protection against the toxicity of chemical warfare agents. Small scale preliminary experiments use outdated plasma from the American Red Cross as the starting material for purifying BChE (P06276). Many of the volunteer donor plasma samples are turbid with fat, the donor having eaten fatty food before the blood draw. The turbid fat interferes with enzyme assays performed in the spectrophotometer and with column chromatography. Our goal was to find a method to remove fat from plasma without loss of BChE activity. Satisfactory delipidation was achieved by adding a solution of 10% dextran sulfate and calcium chloride to fatty plasma, followed by centrifugation, and filtration through a 0.8 μm filter. Treatment with Aerosil also delipidated fatty plasma, but was accompanied by loss of 50% of the plasma volume. BChE activity and the BChE isozyme pattern on nondenaturing gel electrophoresis were unaffected by delipidation. BChE in delipidated plasma was efficiently captured by immobilized monoclonal antibodies B2 18-5 and mAb2. The immunopurified BChE was released from antibody binding with acid and visualized as a highly enriched, denatured BChE preparation by SDS gel electrophoresis. In conclusion, delipidation with dextran sulfate/CaCl2 preserves BChE activity and the tetramer structure of BChE.

KW - Aerosil 380F

KW - Butyrylcholinesterase

KW - Delipidation

KW - Dextran sulfate

KW - Fatty plasma

KW - Monoclonal antibodies

UR - http://www.scopus.com/inward/record.url?scp=85042140835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042140835&partnerID=8YFLogxK

U2 - 10.3389/fphar.2018.00117

DO - 10.3389/fphar.2018.00117

M3 - Article

C2 - 29497381

AN - SCOPUS:85042140835

VL - 9

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

IS - FEB

M1 - 117

ER -